{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:18:01Z","timestamp":1793085481412,"version":"4.5.0"},"reference-count":182,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Chronic kidney disease is highly prevalent worldwide. The decline of renal function is associated with inadequate removal of a variety of uremic toxins that exert detrimental effects on cells functioning, thus affecting the cardiovascular system. The occurrence of cardiovascular aberrations in CKD is related to the impact of traditional risk factors and non-traditional CKD-associated risk factors, including anemia; inflammation; oxidative stress; the presence of some uremic toxins; and factors related to the type, frequency of dialysis and the composition of dialysis fluid. Cardiovascular diseases are the most frequent cause for the deaths of patients with all stages of renal failure. The kidney is one of the vital sources of antioxidant enzymes, therefore, the impairment of this organ is associated with decreased levels of these enzymes as well as increased levels of pro-oxidants. Uremic toxins have been shown to play a vital role in the onset of oxidative stress. Hemodialysis itself also enhances oxidative stress. Elevated oxidative stress has been demonstrated to be strictly related to kidney and cardiac damage as it aggravates kidney dysfunction and induces cardiac hypertrophy. Antioxidant therapies may prove to be beneficial since they can decrease oxidative stress, reduce uremic cardiovascular toxicity and improve survival.<\/jats:p>","DOI":"10.3390\/antiox9111079","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T09:09:32Z","timestamp":1604394572000},"page":"1079","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases"],"prefix":"10.3390","volume":"9","author":[{"given":"Jacek","family":"Rysz","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Franczyk","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"\u0141awi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3322-5655","authenticated-orcid":false,"given":"Anna","family":"Gluba-Brz\u00f3zka","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D. (2016). Global Prevalence of Chronic Kidney Disease\u2014A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8567275","DOI":"10.1155\/2019\/8567275","article-title":"Oxidative Balance and Inflammation in Hemodialysis Patients: Biomarkers of Cardiovascular Risk?","volume":"2019","author":"Russa","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Navarro-Garcia, J.A., Rodriguez-Sanchez, E., Aceves-Ripoll, J., Abarca-Zabalia, J., Susmozas-Sanchez, A., Gonzalez Lafuente, L., Bada-Bosch, T., Hernandez, E., Merida-Herrero, E., and Praga, M. (2019). Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration. Nutrients, 11.","DOI":"10.3390\/nu11112809"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","article-title":"Cardiovascular disease in dialysis patients","volume":"33","author":"Cozzolino","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1523-1755.2000.00236.x","article-title":"Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysis","volume":"58","author":"Tepel","year":"2000","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.V83475","article-title":"Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors","volume":"8","author":"Becker","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1046\/j.1523-1755.1999.00613.x","article-title":"Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis","volume":"56","author":"Boaz","year":"1999","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000479250","article-title":"The Cardiovascular Burden in End-Stage Renal Disease","volume":"191","author":"Cozzolino","year":"2017","journal-title":"Contrib. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chronic Kidney Disease Prognosis Consortium, Matsushita, K., van der Velde, M., Astor, B.C., Woodward, M., Levey, A.S., de Jong, P.E., Coresh, J., and Gansevoort, R.T. (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet, 375, 2073\u20132081.","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: A randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/ki.1996.201","article-title":"Outcome and risk factors of ischemic heart disease in chronic uremia","volume":"49","author":"Parfrey","year":"1996","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1046\/j.1523-1755.2001.00040.x","article-title":"Coronary artery disease in uremia: Etiology, diagnosis, and therapy","volume":"60","author":"Goldsmith","year":"2001","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1681\/ASN.V13suppl_1s28","article-title":"Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients","volume":"13","author":"Qureshi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2009.06.034","article-title":"Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: The Hisayama study","volume":"55","author":"Nakano","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2215\/CJN.04320709","article-title":"Coronary calcification in patients with chronic kidney disease and coronary artery disease","volume":"4","author":"Nakamura","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000090182","article-title":"Atherosclerosis and vascular calcification in chronic renal failure","volume":"28","author":"Campean","year":"2005","journal-title":"Kidney Blood Press. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000299798","article-title":"Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation","volume":"31","author":"Tumur","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Podkowi\u0144ska, A., and Formanowicz, D. (2020). Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease. Antioxidants (Basel), 9.","DOI":"10.3390\/antiox9080752"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2003.11.039","article-title":"Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure","volume":"43","author":"Block","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000368940","article-title":"Update on inflammation in chronic kidney disease","volume":"39","author":"Akchurin","year":"2015","journal-title":"Blood Purif."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1179551418792257","DOI":"10.1177\/1179551418792257","article-title":"The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease","volume":"11","author":"Kosmas","year":"2018","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fped.2018.00161","article-title":"Malnutrition in Chronic Kidney Disease","volume":"6","author":"Iorember","year":"2018","journal-title":"Front. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/2230-8210.93743","article-title":"Protein energy wasting in chronic kidney disease: An update with focus on nutritional interventions to improve outcomes","volume":"16","author":"Jadeja","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000479256","article-title":"Inflammation and Protein-Energy Wasting in the Uremic Milieu","volume":"191","author":"Jankowska","year":"2017","journal-title":"Contrib. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Florens, N., Calzada, C., Lyasko, E., Juillard, L., and Soulage, C.O. (2016). Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. Toxins (Basel), 8.","DOI":"10.3390\/toxins8120376"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2006091006","article-title":"Lipoprotein metabolism and lipid management in chronic kidney disease","volume":"18","author":"Kwan","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Dennis, J.M., and Witting, P.K. (2017). Protective Role for Antioxidants in Acute Kidney Disease. Nutrients, 9.","DOI":"10.3390\/nu9070718"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/jnnp-2019-320526","article-title":"Disentangling the multiple links between renal dysfunction and cerebrovascular disease","volume":"91","author":"Kelly","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1089\/ars.2006.8.1865","article-title":"Redefining oxidative stress","volume":"8","author":"Jones","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1089\/ars.2012.4638","article-title":"Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis","volume":"17","author":"Tavakoli","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0891-5849(96)00233-X","article-title":"Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure","volume":"21","author":"Nguyen","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"ref_40","first-page":"331","article-title":"Blood enzymes and oxidative stress in chronic kidney disease: A cross sectional study","volume":"41","author":"Fernelius","year":"2011","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Rapa, S.F., Di Iorio, B.R., Campiglia, P., Heidland, A., and Marzocco, S. (2019). Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010263"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1681\/ASN.V12122747","article-title":"Oxidative stress and endothelial function in chronic renal failure","volume":"12","author":"Annuk","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1744-9987.2010.00883.x","article-title":"Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease","volume":"15","author":"Fujii","year":"2011","journal-title":"Ther. Apher. Dial."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12986-015-0044-z","article-title":"Mitochondria: A new therapeutic target in chronic kidney disease","volume":"12","author":"Granata","year":"2015","journal-title":"Nutr. Metab. (Lond.)"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1073\/pnas.051627098","article-title":"Increased mitochondrial oxidative stress in the Sod2 (+\/\u2212) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis","volume":"98","author":"Kokoszka","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.mad.2006.12.008","article-title":"Age-related changes in mitochondrial function and antioxidative enzyme activity in fischer 344 rats","volume":"128","author":"Meng","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"ref_47","unstructured":"Small, D.G. (2020, August 10). Glenda Oxidative Stress and Antioxidant Therapy in Chronic Kidney and Cardiovascular Disease. Available online: https:\/\/www.intechopen.com\/books\/oxidative-stress-and-chronic-degenerative-diseases-a-role-for-antioxidants\/oxidative-stress-and-antioxidant-therapy-in-chronic-kidney-and-cardiovascular-disease."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/cphy.c120028","article-title":"Immune and inflammatory role in renal disease","volume":"3","author":"Imig","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/db08-0057","article-title":"Oxidative stress as a major culprit in kidney disease in diabetes","volume":"57","author":"Forbes","year":"2008","journal-title":"Diabetes"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2006.03.047","article-title":"Serum myeloperoxidase and mortality in maintenance hemodialysis patients","volume":"48","author":"Brennan","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Nuhu, F., and Bhandari, S. (2018). Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia. Pharmaceuticals (Basel), 11.","DOI":"10.3390\/ph11040103"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1349-7006.2008.00939.x","article-title":"Binding of monosodium urate crystals with idiotype protein efficiently promote dendritic cells to induce cytotoxic T cells","volume":"99","author":"Sakamaki","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10715762.2015.1125996","article-title":"The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells","volume":"50","author":"Saldanha","year":"2016","journal-title":"Free Radic. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00775-007-0229-7","article-title":"NADH oxidase activity of rat and human liver xanthine oxidoreductase: Potential role in superoxide production","volume":"12","author":"Maia","year":"2007","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_56","first-page":"638732","article-title":"The role of uric acid in kidney fibrosis: Experimental evidences for the causal relationship","volume":"2014","author":"Kim","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_57","first-page":"682","article-title":"Antioxidant Enzymes status in South Indian Hemodialysis patients","volume":"2","author":"Reddy","year":"2011","journal-title":"Int. J. Biol. Med. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/0886022X.2018.1487857","article-title":"Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease","volume":"40","author":"Suchitra","year":"2018","journal-title":"Ren. Fail."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3081856","DOI":"10.1155\/2017\/3081856","article-title":"Oxidative Stress in Hemodialysis Patients: A Review of the Literature","volume":"2017","author":"Liakopoulos","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00005-017-0496-0","article-title":"Oxidative Stress in Kidney Diseases: The Cause or the Consequence?","volume":"66","author":"Krata","year":"2018","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000014347","article-title":"Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis","volume":"16","author":"Chen","year":"1998","journal-title":"Blood Purif."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Granata, S., Zaza, G., Simone, S., Villani, G., Latorre, D., Pontrelli, P., Carella, M., Schena, F.P., Grandaliano, G., and Pertosa, G. (2009). Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genom., 10.","DOI":"10.1186\/1471-2164-10-388"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"F840","DOI":"10.1152\/ajprenal.00511.2012","article-title":"Role of Nox2 in diabetic kidney disease","volume":"304","author":"You","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2014.07.003","article-title":"Complement-dependent NADPH oxidase enzyme activation in renal ischemia\/reperfusion injury","volume":"74","author":"Simone","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fcell.2015.00035","article-title":"Redox interplay between mitochondria and peroxisomes","volume":"3","author":"Lismont","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1681\/ASN.2007020149","article-title":"Angiotensin II-induced reactive oxygen species and the kidney","volume":"18","author":"Sachse","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diabetes.53.1.166","article-title":"Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice","volume":"53","author":"Flyvbjerg","year":"2004","journal-title":"Diabetes"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ndt\/gfq554","article-title":"Dialysis modality-dependent changes in serum metabolites: Accumulation of inosine and hypoxanthine in patients on haemodialysis","volume":"26","author":"Choi","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0891-5849(00)00338-5","article-title":"Superoxides from mitochondrial complex III: The role of manganese superoxide dismutase","volume":"29","author":"Raha","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00418-009-0563-7","article-title":"Peroxisomes and reactive oxygen species, a lasting challenge","volume":"131","author":"Angermuller","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1600-0854.2009.00966.x","article-title":"Hitchhiking of Cu\/Zn superoxide dismutase to peroxisomes\u2014Evidence for a natural piggyback import mechanism in mammals","volume":"10","author":"Islinger","year":"2009","journal-title":"Traffic"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.freeradbiomed.2011.04.036","article-title":"Segment-specific overexpression of redoxins after renal ischemia and reperfusion: Protective roles of glutaredoxin 2, peroxiredoxin 3, and peroxiredoxin 6","volume":"51","author":"Godoy","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Su, X., Xu, B., Yan, B., Qiao, X., and Wang, L. (2017). Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187550"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5455\/oams.130312.rv.001","article-title":"Is it oxidative stress or free radical stress and why does it matter?","volume":"1","author":"Lipinski","year":"2012","journal-title":"Oxid. Antioxid. Med. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0968-0004(02)02191-6","article-title":"Nanotransducers in cellular redox signaling: Modification of thiols by reactive oxygen and nitrogen species","volume":"27","author":"Cooper","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1073\/pnas.93.6.2353","article-title":"Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis","volume":"93","author":"Miyata","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Friedlander","year":"1996","journal-title":"Kidney Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000321752","article-title":"Markers and possible uremic toxins: Japanese experiences","volume":"168","author":"Kinugasa","year":"2011","journal-title":"Contrib. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1006\/bbrc.2001.5901","article-title":"RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells","volume":"288","author":"Zill","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1523-1755.2002.00115.x","article-title":"AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression","volume":"61","author":"Boulanger","year":"2002","journal-title":"Kidney Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1080\/10715762.2019.1690651","article-title":"Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis","volume":"53","author":"Colombo","year":"2019","journal-title":"Free Radic. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.109.161992","article-title":"SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells","volume":"333","author":"Funk","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1440-1797.2010.01339.x","article-title":"Renal PPARgamma mRNA expression increases with impairment of renal function in patients with chronic kidney disease","volume":"15","author":"Lepenies","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2012.02.027","article-title":"Reduction of renal lipid content and proteinuria by a PPAR-gamma agonist in a rat model of angiotensin II-induced hypertension","volume":"682","author":"Sakamoto","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"19633","DOI":"10.1074\/jbc.272.32.19633","article-title":"Oxidative decay of DNA","volume":"272","author":"Beckman","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000014377","article-title":"The involvement of oxidative stress in the progression of renal injury","volume":"17","author":"Haugen","year":"1999","journal-title":"Blood Purif."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000297290","article-title":"Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes","volume":"31","author":"Fujii","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1159\/000109148","article-title":"Involvement of NADPH oxidases in cardiac remodelling and heart failure","volume":"27","author":"Sirker","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0008-6363(00)00117-6","article-title":"Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: A possible explanation for the increased cardiovascular risk in these patients","volume":"47","author":"Clermont","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.CIR.101.9.1002","article-title":"Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer","volume":"101","author":"Miyazaki","year":"2000","journal-title":"Circulation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.ATV.20.6.1430","article-title":"Interactions of oxidants with vascular signaling systems","volume":"20","author":"Wolin","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0022-2275(20)32089-7","article-title":"Oxidants and antioxidants in atherogenesis. An appraisal","volume":"40","author":"Parthasarathy","year":"1999","journal-title":"J. Lipid Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","article-title":"Increased myocardial NADPH oxidase activity in human heart failure","volume":"41","author":"Heymes","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.0000091084.46500.BB","article-title":"Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment","volume":"108","author":"Maack","year":"2003","journal-title":"Circulation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.yjmcc.2007.01.009","article-title":"NADPH oxidase-dependent redox signaling in human heart failure: Relationship between the left and right ventricle","volume":"42","author":"Nediani","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.ATV.0000043452.30772.18","article-title":"The reactive adventitia: Fibroblast oxidase in vascular function","volume":"22","author":"Rey","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cardiores.2007.02.015","article-title":"NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts","volume":"75","author":"An","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","article-title":"Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells","volume":"69","author":"Yamamoto","year":"2006","journal-title":"Kidney Int."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ndt\/gfm861","article-title":"Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats","volume":"23","author":"Adijiang","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_104","first-page":"165","article-title":"Oxidative stress in chronic kidney disease","volume":"9","author":"Modaresi","year":"2015","journal-title":"Iran J. Kidney Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4239\/wjd.v3.i3.54","article-title":"ApoE isoforms, treatment of diabetes and the risk of coronary heart disease","volume":"3","author":"Ehara","year":"2012","journal-title":"World J. Diabetes"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"14849","DOI":"10.1073\/pnas.1101507108","article-title":"Identification and characterization of a functional mitochondrial angiotensin system","volume":"108","author":"Abadir","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/HYPERTENSIONAHA.108.123802","article-title":"Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients","volume":"53","author":"Kobori","year":"2009","journal-title":"Hypertension"},{"key":"ref_109","first-page":"9","article-title":"Role of RAAS inhibition in preventing left ventricular remodeling in patients post myocardial infarction","volume":"47","author":"Morrone","year":"2010","journal-title":"Heart Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1098\/rstb.2005.1772","article-title":"NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology","volume":"360","author":"Cave","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.97.22.2222","article-title":"Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension","volume":"97","author":"Taddei","year":"1998","journal-title":"Circulation"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"T\u00f3th, A., Balogh, E., and Jeney, V. (2020). Regulation of Vascular Calcification by Reactive Oxygen Species. Antioxidants, 9.","DOI":"10.3390\/antiox9100963"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Pedriali, G., Morciano, G., Patergnani, S., Cimaglia, P., Morelli, C., Mikus, E., Ferrari, R., Gasbarro, V., Giorgi, C., and Wieckowski, M.R. (2020). Aortic Valve Stenosis and Mitochondrial Dysfunctions: Clinical and Molecular Perspectives. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144899"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S4822","article-title":"Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis","volume":"5","author":"Rennenberg","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40620-015-0260-7","article-title":"Abdominal aortic calcification in patients with CKD","volume":"30","author":"Peeters","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2019.12.006","article-title":"Oxidative stress contributes to vascular calcification in patients with chronic kidney disease","volume":"138","author":"Huang","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0891-5849(01)00610-4","article-title":"Oxidative stress modulates osteoblastic differentiation of vascular and bone cells","volume":"31","author":"Mody","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.M800021200","article-title":"Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling","volume":"283","author":"Byon","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1074\/jbc.M306972200","article-title":"MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors","volume":"278","author":"Cheng","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","article-title":"Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals","volume":"115","author":"Shao","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000370250","article-title":"High phosphorus level leads to aortic calcification via \u03b2-catenin in chronic kidney disease","volume":"41","author":"Yao","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yexcr.2016.06.007","article-title":"WNT\/\u03b2-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression","volume":"345","author":"Cai","year":"2016","journal-title":"Exp. Cell Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.17.4.680","article-title":"Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients","volume":"17","author":"Parhami","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/08860220902875182","article-title":"Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway","volume":"31","author":"You","year":"2009","journal-title":"Ren. Fail."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V","article-title":"Runt homology domain proteins in osteoblast differentiation: AML3\/CBFA1 is a major component of a bone-specific complex","volume":"66","author":"Banerjee","year":"1997","journal-title":"J. Cell. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1523-1755.2003.00044.x","article-title":"AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients","volume":"64","author":"Gausson","year":"2003","journal-title":"Kidney Int."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"14443","DOI":"10.1074\/jbc.M010021200","article-title":"Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells","volume":"276","author":"Lai","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"36181","DOI":"10.1074\/jbc.M206057200","article-title":"Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1\/Runx2","volume":"277","author":"Xiao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"23934","DOI":"10.1074\/jbc.M109881200","article-title":"The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells","volume":"277","author":"Ziros","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1074\/jbc.275.6.4453","article-title":"MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1","volume":"275","author":"Xiao","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1172\/JCI112196","article-title":"Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking","volume":"76","author":"Snyder","year":"1985","journal-title":"J. Clin. Investig."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0609.1995.tb00705.x","article-title":"Increased susceptibility of microcytic red blood cells to in vitro oxidative stress","volume":"55","author":"Pujades","year":"1995","journal-title":"Eur. J. Haematol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1080\/10715760802459879","article-title":"Iron-deficiency anaemia enhances red blood cell oxidative stress","volume":"42","author":"Nagababu","year":"2008","journal-title":"Free Radic. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccc.2004.01.001","article-title":"Physiologic aspects of anemia","volume":"20","author":"Hebert","year":"2004","journal-title":"Crit. Care Clin."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"343571","DOI":"10.1155\/2015\/343571","article-title":"Erythrocyte Catalase Activity in More Frequent Microcytic Hypochromic Anemia: Beta-Thalassemia Trait and Iron Deficiency Anemia","volume":"2015","author":"Lazarte","year":"2015","journal-title":"Adv. Hematol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1089\/ars.2012.4867","article-title":"Hemoglobin redox reactions and red blood cell aging","volume":"18","author":"Rifkind","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000204683","article-title":"Serum selenium status in children with iron deficiency anemia","volume":"88","author":"Yetgin","year":"1992","journal-title":"Acta Haematol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/2040620712440071","article-title":"The role of intravenous iron in the treatment of anemia in cancer patients","volume":"3","author":"Steinmetz","year":"2012","journal-title":"Ther. Adv. Hematol."},{"key":"ref_141","first-page":"146","article-title":"Serum paraoxonase activities in hemodialyzed uremic patients: Cohort study","volume":"42","author":"Juretic","year":"2001","journal-title":"Croat. Med. J."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2215\/CJN.06130710","article-title":"Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients","volume":"6","author":"Chen","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2008020227","article-title":"GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients","volume":"20","author":"Lin","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000014381","article-title":"Imbalance of oxidants and antioxidants in haemodialysis patients","volume":"17","author":"Canaud","year":"1999","journal-title":"Blood Purif."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy","volume":"58","author":"Dai","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_146","first-page":"CD008176","article-title":"Antioxidants for chronic kidney disease","volume":"10","author":"Jun","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.nutr.24.012003.132446","article-title":"Vitamin E, oxidative stress, and inflammation","volume":"25","author":"Singh","year":"2005","journal-title":"Annu. Rev. Nutr."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2014.03.035","article-title":"Natural forms of vitamin E: Metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy","volume":"72","author":"Jiang","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","article-title":"Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial","volume":"356","author":"Boaz","year":"2000","journal-title":"Lancet"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1523-1755.2002.00518.x","article-title":"Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure","volume":"62","author":"Amann","year":"2002","journal-title":"Kidney Int."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1159\/000142935","article-title":"Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury?","volume":"109","author":"Koyner","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s002280050668","article-title":"Plasma ascorbic acid in patients undergoing chronic haemodialysis","volume":"55","author":"Wang","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2004100850","article-title":"Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients","volume":"16","author":"Deicher","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/sdi.12443","article-title":"Can Outcomes be Improved in Dialysis Patients by Optimizing Trace Mineral, Micronutrient, and Antioxidant Status? The Impact of Vitamins and their Supplementation","volume":"29","author":"Chazot","year":"2016","journal-title":"Semin. Dial."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Jankowska, M., Rutkowski, B., and Debska-Slizien, A. (2017). Vitamins and Microelement Bioavailability in Different Stages of Chronic Kidney Disease. Nutrients, 9.","DOI":"10.3390\/nu9030282"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ki.2010.22","article-title":"Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes","volume":"77","author":"Deb","year":"2010","journal-title":"Kidney Int."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1681\/ASN.2009121236","article-title":"Blockade of Wnt\/\u03b2-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury","volume":"22","author":"He","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: A multicenter, randomized, controlled trial","volume":"54","author":"Akizawa","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000063324","article-title":"Effect of oral adsorbent (AST-120) on renal function, acquired renal cysts and aortic calcification in rats with adriamycin nephropathy","volume":"92","author":"Ishikawa","year":"2002","journal-title":"Nephron"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11095-007-9248-x","article-title":"An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure","volume":"24","author":"Shimoishi","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfp007","article-title":"Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress","volume":"24","author":"Fujii","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_163","unstructured":"Nakai, K.F.H., Kono, K., and Goto, S. (2010, January 25\u201328). Effect of AST-120 on cardiac abnormalities in patients with chronic kidney disease (CKD) stage 4 and 5. Proceedings of the XLVII ERA-EDTA Congress\u2014II DGfN Congress, Munich, Germany."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2005.05.002","article-title":"Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages","volume":"165","author":"Mayo","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00500.2007","article-title":"Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction","volume":"294","author":"Quiroz","year":"2008","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/ENDO:27:2:189","article-title":"A review of the multiple actions of melatonin on the immune system","volume":"27","author":"Guerrero","year":"2005","journal-title":"Endocrine"},{"key":"ref_167","first-page":"69","article-title":"A review of biological and pharmacological actions of melatonin: Oxidant and prooxidant properties","volume":"4","author":"Eghbal","year":"2016","journal-title":"Pharm. Bioprocess."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fmicb.2017.01066","article-title":"Melatonin Reduces Oxidative Stress Damage Induced by Hydrogen Peroxide in Saccharomyces cerevisiae","volume":"8","author":"Sempere","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_169","first-page":"659","article-title":"Melatonin, advanced oxidation protein products and total antioxidant capacity as seminal parameters of prooxidant-antioxidant balance and their connection with expression of metalloproteinases in context of male fertility","volume":"68","author":"Kratz","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-079X.2010.00814.x","article-title":"Update on the use of melatonin in pediatrics","volume":"50","author":"Gitto","year":"2011","journal-title":"J. Pineal Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41440-019-0223-9","article-title":"Melatonin in chronic kidney disease: A promising chronotherapy targeting the intrarenal renin\u2013angiotensin system","volume":"42","author":"Rahman","year":"2019","journal-title":"Hypertens. Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41440-018-0066-9","article-title":"Aerobic exercise enhanced endothelium-dependent vasorelaxation in mesenteric arteries in spontaneously hypertensive rats: The role of melatonin","volume":"41","author":"Qiu","year":"2018","journal-title":"Hypertens. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/hr.2016.103","article-title":"Effect of long-term treatment with melatonin on vascular markers of oxidative stress\/inflammation and on the anticontractile activity of perivascular fat in aging mice","volume":"40","author":"Favero","year":"2017","journal-title":"Hypertens. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.2009.00693.x","article-title":"Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension","volume":"47","author":"Sehirli","year":"2009","journal-title":"J. Pineal Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0735-1097(00)01093-7","article-title":"N-acetylcysteine improves coronary and peripheral vascular function","volume":"37","author":"Andrews","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","article-title":"Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome","volume":"25","author":"Giam","year":"2016","journal-title":"Heart Lung Circ."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5301\/ijao.5000078","article-title":"Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin","volume":"35","author":"Mehmetoglu","year":"2012","journal-title":"Int. J. Artif. Organs"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.ajkd.2016.08.041","article-title":"Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial","volume":"69","author":"Rivara","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/hc0302.102618","article-title":"The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part I: Oxidative stress and atherogenesis","volume":"105","author":"Nickenig","year":"2002","journal-title":"Circulation"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.ATV.20.3.645","article-title":"Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress","volume":"20","author":"Pueyo","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/10715760100301291","article-title":"Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells","volume":"35","author":"Imaeda","year":"2001","journal-title":"Free Radic. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","article-title":"Left ventricular hypertrophy in nondiabetic predialysis CKD","volume":"46","author":"Paoletti","year":"2005","journal-title":"Am. J. Kidney Dis."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/11\/1079\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:28:47Z","timestamp":1760178527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/9\/11\/1079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":182,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["antiox9111079"],"URL":"https:\/\/doi.org\/10.3390\/antiox9111079","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]}}}